Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine the efficacy, safety, tolerability, and patient satisfaction associated with the treatment of epidermoid cysts with injected 1.5% sodium tetradecyl sulfate (STS) foam.


Clinical Trial Description

The primary objective is to determine the efficacy of STS foam injection on EIC with an endpoint of clinical resolution and cyst wall destruction on histology. Enrolled subjects will undergo aspiration of cyst contents through an 18g needle immediately followed by injection of 1.5% STS foam (until the cyst is full and foam is flowing out of the injection site) followed by surgical excision 60 days later. The foam will be created by diluting 3% STS with an equal volume of normal saline then mixing with air in a 1:4 ratio using a female-to-female coupler. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05597995
Study type Interventional
Source Goldman, Butterwick, Fitzpatrick and Groff
Contact Andrea Pacheco
Phone 8586571004
Email apacheco@clderm.com
Status Not yet recruiting
Phase Phase 2
Start date November 1, 2022
Completion date May 30, 2023